A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation

Author:

Heitzinger Gregor1ORCID,Spinka Georg1,Koschatko Sophia1,Baumgartner Clemens2,Dannenberg Varius1,Halavina Kseniya1,Mascherbauer Katharina1,Nitsche Christian1ORCID,Dona Caroliná1,Koschutnik Matthias1ORCID,Kammerlander Andreas1ORCID,Winter Max-Paul1,Strunk Guido3,Pavo Noemi1ORCID,Kastl Stefan1,Hülsmann Martin1,Rosenhek Raphael1,Hengstenberg Christian1ORCID,Bartko Philipp E1ORCID,Goliasch Georg14ORCID

Affiliation:

1. Department of Internal Medicine II, Medical University of Vienna , Währinger Gürtel 18-20, 1090 Vienna , Austria

2. Department of Internal Medicine III, Medical University of Vienna , Währinger Gürtel 18-20, 1090 Vienna , Austria

3. Complexity-Research , Schönbrunner Str. 32 / 20A, 1050 Vienna , Austria

4. Herzzentrum Währing , Theresiengasse 43, 1180 Vienna , Austria

Abstract

Abstract Aims Secondary tricuspid regurgitation (sTR) is the most frequent valvular heart disease and has a significant impact on mortality. A high burden of comorbidities often worsens the already dismal prognosis of sTR, while tricuspid interventions remain underused and initiated too late. The aim was to examine the most powerful predictors of all-cause mortality in moderate and severe sTR using machine learning techniques and to provide a streamlined approach to risk-stratification using readily available clinical, echocardiographic and laboratory parameters. Methods and results This large-scale, long-term observational study included 3359 moderate and 1509 severe sTR patients encompassing the entire heart failure spectrum (preserved, mid-range and reduced ejection fraction). A random survival forest was applied to investigate the most important predictors and group patients according to their number of adverse features. The identified predictors and thresholds, that were associated with significantly worse mortality were lower glomerular filtration rate (<60 mL/min/1.73m2), higher NT-proBNP, increased high sensitivity C-reactive protein, serum albumin < 40 g/L and hemoglobin < 13 g/dL. Additionally, grouping patients according to the number of adverse features yielded important prognostic information, as patients with 4 or 5 adverse features had a fourfold risk increase in moderate sTR [4.81(3.56–6.50) HR 95%CI, P < 0.001] and fivefold risk increase in severe sTR [5.33 (3.28–8.66) HR 95%CI, P < 0.001]. Conclusion This study presents a streamlined, machine learning-derived and internally validated approach to risk-stratification in patients with moderate and severe sTR, that adds important prognostic information to aid clinical-decision-making.

Funder

Austrian Science Fund

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference37 articles.

1. Burden of tricuspid regurgitation in patients diagnosed in the community setting;Topilsky;JACC Cardiovasc Imaging,2019

2. ESC/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS);Vahanian;Eur Heart J,2021

3. Management of tricuspid valve regurgitation: position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease;Antunes;Eur J Cardiothorac Surg,2017

4. Natural history of functional tricuspid regurgitation: implications of quantitative Doppler assessment;Bartko;JACC Cardiovasc Imaging,2019

5. Natural course of nonsevere secondary tricuspid regurgitation;Spinka;J Am Soc Echocardiogr,2021

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3